Kelo outcome shows Atlantic Yards risk

The outcome of New York's embattled eminent domain development projects is called into question by the economic development project which made them possible.

The Pfizer research facility at the center of the Kelo v. New London Supreme Court decision is closing, taking over 1,400 jobs with it. The 5-4 Kelo decision allowed New London, CT to use eminent domain to condemn private property for the "public purpose" of commercial development near a new Pfizer research facility. The city, which gave Pfizer a property tax break of 80% for the first ten years, spent $80 million preparing the seized property to build the condominiums and hotels they promised to draw Pfizer into town. Development was supposed to bring 3,000 jobs to the area.